ClinicalTrials.gov
ClinicalTrials.gov Menu

The Prognostic Value of Troponin T for Long-term Outcome After Cardiac Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00468598
Recruitment Status : Completed
First Posted : May 3, 2007
Last Update Posted : March 10, 2015
Sponsor:
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland

Brief Summary:
This survey has two aims. First, we would like to be informed about the health condition of our patients two years following heart surgery at University Hospital, Basel. Second, we are interested in determining whether a patient's long-term outcome can be predicted by the analysis of blood samples taken shortly after heart surgery.Troponin T, the blood parameter that we are interested in, is routinely assessed in the Intensive Care Unit. The purpose of this survey is to determine whether or not it is also possible to infer the long-term outcome from this blood parameter.

Condition or disease
Heart; Dysfunction Postoperative, Cardiac Surgery Adverse Anesthesia Outcome

  Show Detailed Description

Study Type : Observational
Actual Enrollment : 3000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Prognostic Value of Troponin T for Long-term Outcome After Cardiac Surgery
Study Start Date : January 2007
Actual Primary Completion Date : March 2012
Actual Study Completion Date : March 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Surgery
U.S. FDA Resources




Primary Outcome Measures :
  1. Death and/or major adverse cardiac events [ Time Frame: 12 months after cardiac surgery ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
adults patients undergoing on-pump cardiac surgery at University Hospital Basel
Criteria

Inclusion Criteria:

  • On-pump cardiac surgery at University Hospital of Basel

Exclusion Criteria:

  • Off-pump cardiac surgery
  • Procedures requiring hypothermic cardiocirculatory arrest

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00468598


Locations
Switzerland
University Hospital
Basel, Basel-Stadt, Switzerland, 4052
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Investigators
Principal Investigator: Miodrag Filipovic, MD Anesthesiology department, University Hospital of Basel

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT00468598     History of Changes
Other Study ID Numbers: 06/07
First Posted: May 3, 2007    Key Record Dates
Last Update Posted: March 10, 2015
Last Verified: March 2015

Keywords provided by University Hospital, Basel, Switzerland:
troponin
long-term outcome
on-pump cardiac surgery